Related references
Note: Only part of the references are listed.Protective Efficacy and Immunogenicity of an Adenoviral Vector Vaccine Encoding the Codon-Optimized F Protein of Respiratory Syncytial Virus
Rebekka Kohlmann et al.
JOURNAL OF VIROLOGY (2009)
The Secreted Form of Respiratory Syncytial Virus G Glycoprotein Helps the Virus Evade Antibody-Mediated Restriction of Replication by Acting as an Antigen Decoy and through Effects on Fc Receptor-Bearing Leukocytes
Alexander Bukreyev et al.
JOURNAL OF VIROLOGY (2008)
Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection
Jae-Rang Yu et al.
JOURNAL OF VIROLOGY (2008)
Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats
Hoyin Mok et al.
JOURNAL OF VIROLOGY (2007)
Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques
Matthew B. Elliott et al.
VACCINE (2007)
The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans
PF Wright et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector
L Martinez-Sobrido et al.
JOURNAL OF VIROLOGY (2006)
Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus
T Takimoto et al.
VIRAL IMMUNOLOGY (2005)
Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants
RA Karron et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Evaluation of BBG2Na in infant macaques:: specific immune responses after vaccination and RSV challenge
L de Waal et al.
VACCINE (2004)
Vβ14+ T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV
TR Johnson et al.
JOURNAL OF VIROLOGY (2004)
Human CD8+ T cell responses against five newly identified respiratory syncytial virus-derived epitopes
J Heidema et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV
TR Johnson et al.
JOURNAL OF VIROLOGY (2004)
Adjuvants recognized by toll-like receptors inhibit the induction of polarized type 2 T cell responses by natural attachment (G) protein of respiratory syncytial virus
GE Hancock et al.
VACCINE (2003)
Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis
PA Piedra et al.
VACCINE (2003)
Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection
RL de Swart et al.
JOURNAL OF VIROLOGY (2002)
Respiratory syncytial virus fusion protein mediates inhibition of mitogen-induced T-Cell proliferation by contact
J Schlender et al.
JOURNAL OF VIROLOGY (2002)
Respiratory syncytial virus infection suppresses lung CD8(+) T-cell effector activity and peripheral CD8(+) T-cell memory in the respiratory tract
J Chang et al.
NATURE MEDICINE (2002)
Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults
UF Power et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3
AC Schmidt et al.
JOURNAL OF VIROLOGY (2001)
Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease
GA Prince et al.
VACCINE (2001)
Respiratory syncytial virus infection of gene gun vaccinated mice induces Th2-driven pulmonary eosinophilia even in the absence of sensitisation to the fusion (F) or attachment (G) protein
GP Bembridge et al.
VACCINE (2000)
Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy
PF Wright et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides
F Cano et al.
VACCINE (2000)
Share Paper
